RDNT · RadNet, Inc.
Market Cap
$5.98B
Shares
78.70M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$76.00
Open$77.66
Day$75.71–78.01
52W close$51.87–84.48
Avg vol 30d765K
Short int9.9M · 12.6% float · 19.5d
Short vol50%
Last earningsAug 10, 2026
DataJan 2020–Sep 2026
Filing10-Q · Aug 10
Up next
Next earnings call
Nov 9, 2026
Est · unconfirmed
· in 7 wks
filed Aug 10, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$2.27B
Trailing 12 months
Net income (TTM)
−$21.12M
Trailing 12 months
Revenue growth YoY
+25.0%
Year over year
Operating margin
3.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
2.3%
Trailing 12 months
Net cash
−$606.26M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+4.2%
Year over year · more shares
Price change (1Y)
-0.8%
Trailing year
Short interest
12.6%
Latest settlement · 19.5 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bearish
Fundamentals
Fair
Quant / Vol
Moderate
Market backdrop
VIX 14.8 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+16%
above
Price vs 50-day avg
+8%
above
RSI (14)
55
neutral
MACD trend
Negative
52-week position
74%
mid-range
Momentum
relative strength
1-month return
−1%
trailing
6-month return
+35%
trailing
YTD return
+7%
this year
Relative strength
+15%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $71 › 200d $66 — 50d above 200d
Institutional flow
Distributing
-4% holders QoQ · +41 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
12.63% of float · ▲ +2.6% MoM · 19.5 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
331 holders — mid 3-yr range
Squeeze score
85
high risk · 0–100
Fundamentals
Revenue growth
+13%
Y/Y
EPS growth
−725%
Y/Y
Free cash flow
$224.7M
Balance sheet
$558.4M
net debt
Quant / Vol
risk profile
Volatility
42%
annualized · 1-yr
Max drawdown
−39%
past year
ATR
3.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 10, 2026
Cash Interest Expense
· full-year 2026
Initiated
$48M – $53M
Free Cash Flow
· full-year 2026
Non-GAAP
Initiated
$115M – $125M
Prior guidance
period ended
· from the 8-K filed Aug 9, 2024
EBITDA (imaging center segment)
· 2024 fiscal year
$257M – $260M
Capital expenditures (imaging center segment)
· 2024 fiscal year
$135M – $145M
Cash interest expense
· 2024 fiscal year
$32M – $37M
Free cash flow (imaging center segment)
· 2024 fiscal year
$72M – $80M
Guided vs delivered
· last 2 settled
Total net revenue
2022
guided $1.35B – $1.4B
$1.43B
Beat +4.0%
Total net revenue
2021 fiscal year
guided $1.3B – $1.35B
$1.32B
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+16%
Bullish
Price vs 50-day avg
+8%
Bullish
RSI (14)
55
Neutral
MACD trend
Negative
Bearish
52-week position
74%
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $71 › 200d $66 — 50d above 200d
Institutional flow
Distributing
-4% holders QoQ · +41 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
12.63% of float · ▲ +2.6% MoM · 19.5 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
331 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $52
Now $76 · 74%
Range high $84
vs 200-day avg +16%
vs 50-day avg +8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RDNT
this stock
RadNet, Inc.
|
$5.98B | +6.5% | +13.0% | — | 12.6% |
|
TMO
Thermo Fisher Scientific Inc.
|
$240.87B | +12.4% | +14.5% | 35.0 | 1.5% |
|
DHR
Danaher Corp /De/
|
$147.37B | -7.5% | +8.5% | 37.2 | 1.4% |
|
NTRA
Natera, Inc.
|
$53.25B | +61.2% | -2.8% | — | 3.8% |
|
IQV
Iqvia Holdings Inc.
|
$44.71B | +18.2% | +41.6% | 33.3 | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RDNT | +0.7% | -1.4% | +35.4% | +0.2% | +6.5% |
| SPY | -0.3% | -0.1% | +20.1% | -0.7% | +11.7% |
| vs SPY | +1.0% | -1.2% | +15.2% | +0.9% | -5.2% |